Management of Acute Allergic Swelling of the Hands
For acute allergic hand swelling without airway involvement, administer oral antihistamines (H1 blockers) combined with cold compresses and close observation; if symptoms are severe or progressive, add a short course of oral corticosteroids and consider intramuscular epinephrine if systemic symptoms develop. 1
Immediate Assessment
Determine if this is isolated hand swelling or part of a systemic reaction:
- Check for urticaria (hives), pruritus, or swelling elsewhere – these indicate histamine-mediated allergic reaction 2, 3
- Assess for respiratory symptoms (wheezing, throat tightness, difficulty breathing) or cardiovascular symptoms (hypotension, dizziness) – these require immediate epinephrine 1
- Ask about recent insect stings, food exposure, or new medications – helps identify trigger 1
Treatment Algorithm Based on Severity
Mild to Moderate Hand Swelling (No Systemic Symptoms)
First-line treatment:
- Oral H1 antihistamine immediately: Second-generation agents like cetirizine 10-20 mg or loratadine 10 mg are preferred over first-generation diphenhydramine due to less sedation 4
- Cold compresses to the affected hands to reduce local swelling and discomfort 1
- Elevate the hands to reduce edema 1
If inadequate response within 1-2 hours:
- Add H2 blocker: ranitidine 150 mg or famotidine 20 mg orally 1, 3
- Consider oral corticosteroid: prednisone 0.5-1 mg/kg (maximum 60-80 mg) for severe local swelling 1
Severe Hand Swelling or Any Systemic Symptoms
Administer intramuscular epinephrine 0.3-0.5 mg (0.01 mg/kg in children, max 0.3 mg) in the anterolateral thigh immediately if the patient has: 1, 5
- Difficulty breathing or throat tightness
- Hypotension or dizziness
- Widespread urticaria beyond the hands
- Gastrointestinal symptoms (nausea, vomiting, abdominal pain)
Additional acute management:
- IV diphenhydramine 50 mg (1-2 mg/kg in children) 1, 3
- IV methylprednisolone 125 mg (1 mg/kg in children) 1, 3
- H2 blocker: ranitidine 50 mg IV or famotidine 20 mg IV 1, 3
- Transport to emergency department for monitoring 1
Critical Differentiation: Rule Out Bradykinin-Mediated Angioedema
If hand swelling occurs WITHOUT urticaria or pruritus, consider bradykinin-mediated angioedema (hereditary or ACE inhibitor-induced), which requires completely different treatment: 2, 3, 6
- Ask specifically about ACE inhibitor use (lisinopril, enalapril, etc.) 2, 3
- Ask about family history of recurrent swelling episodes 2, 3
- Note if swelling developed slowly over hours rather than minutes 3
For bradykinin-mediated angioedema, standard allergy treatments (antihistamines, corticosteroids, epinephrine) are completely ineffective – these patients require plasma-derived C1 inhibitor concentrate 1000-2000 U IV or icatibant 30 mg subcutaneously and urgent specialist referral 2, 3, 6
Observation and Follow-Up
- Observe for 2-4 hours minimum after treatment to ensure no progression or biphasic reaction 1, 3
- Prescribe epinephrine auto-injector (2 doses) if any systemic symptoms occurred, with instructions for self-administration 1
- Discharge antihistamine regimen: Continue H1 antihistamine (cetirizine 10 mg or loratadine 10 mg) daily for 2-3 days 1
- Consider short corticosteroid course: prednisone 40-60 mg daily for 2-3 days if swelling was severe 1
Referral to Allergist-Immunologist
Refer for allergy consultation if: 1
- Recurrent episodes of unexplained swelling
- Unclear trigger despite thorough history
- Need for skin testing or specific IgE testing to identify allergen 3
- Patient requires education on allergen avoidance and emergency management 1
Common Pitfalls to Avoid
- Do not delay epinephrine if any signs of systemic reaction are present – fatal reactions are associated with delayed epinephrine administration 1, 6
- Do not assume infection – allergic swelling is caused by mediator release, not infection, and antibiotics are not indicated unless secondary infection is evident 1
- Do not use epinephrine, antihistamines, or corticosteroids for bradykinin-mediated angioedema – they waste critical time and are ineffective 2, 3, 6
- Do not discharge patients with oropharyngeal involvement prematurely – these require extended observation due to airway risk 2, 3